|Articles|December 9, 2015
ICON Chooses goBalto for Study Startup
ICON is using Activate for all global studies, which span more than 50 countries.
Advertisement
goBalto announced that ICON has chosen goBalto’s flagship product Activate to bolster ICON’s clinical study startup process on a worldwide basis. ICON is using Activate for all global studies, which span more than 50 countries. ICON has already integrated Activate with its CTMS and data warehouse, and has plans to integrate with its eTMF system.
Read the full
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Patient Recruitment in Clinical Trials: Why the Industry's Longstanding Approach Is No Longer Fit for Purpose
2
Precision Oncology Trials Need to Reflect the Complexity of Cancer Biology
3
ACT Brief: Portfolio-Level Recruitment Strategy, Structural Change Through Systems Thinking, and Kidney Function Preservation in IgAN
4
ACT Brief: Local-First Communication Design, RBQM Financial Impact, and First Oral PCSK9 Inhibitor
5